Omnicell

Omnicell EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Omnicell (OMCL) as of Nov 2, 2026 is 11.67 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 337,000.00 USD — a change of 3,361.42% (higher).

EBITDA

11.67 MUSD

YoY

3,361.42%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Omnicell is 2025 11.67 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Omnicell was 2024 337,000.00 USD. It decreases by 3,361.42% higher compared to the previous year.

The Omnicell EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
44.39 M USD
Jan 1, 2019
78.35 M USD
Jan 1, 2020
35.53 M USD
Jan 1, 2021
89.51 M USD
Jan 1, 2022
-2.32 M USD
Jan 1, 2023
-34.87 M USD
Jan 1, 2024
337,000.00 USD
Jan 1, 2025
11.67 M USD
The Omnicell EBITDA history
YEAREBITDAYoY
11.67 MUSD+3,361.42%
337,000.00USD-100.97%
-34.87 MUSD+1,400.99%
-2.32 MUSD-102.60%
89.51 MUSD+151.95%
35.53 MUSD-54.66%
78.35 MUSD+76.50%
44.39 MUSD+671.50%
5.75 MUSD-11.22%
6.48 MUSD-86.67%
48.63 MUSD-1.92%
49.58 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omnicell Stock analysis

What does Omnicell do? Omnicell Inc. is a leading company in the healthcare industry, specializing in the development and provision of innovative automation solutions for medication and other critical medical supplies. The company was founded in 1992 and is headquartered in Mountain View, California, USA. Over the years, Omnicell has grown into a global company with offices in North America, Europe, Asia, and the Middle East. Omnicell's business model is to offer products, services, and solutions that allow healthcare facilities to optimize their processes, increase patient safety, and save costs. Omnicell provides innovative automation solutions, particularly for medication management, sterilization, and inventory control. Omnicell offers various solutions to improve medication management in clinics. This includes, for example, the medication cabinet, which has an integrated computer system that allows for the quick and easy identification and retrieval of needed medications. Omnicell also offers solutions for sterilizing medical materials to ensure patient safety, as well as automated storage systems for managing medical supplies. In recent years, the company has focused heavily on developing solutions to improve patient safety. One example is Omnicell's Medical Intelligence platform, which automatically detects and notifies of medication errors and other issues, thereby enhancing patient safety. Omnicell's products are used by a wide range of healthcare facilities, from small doctor's offices to large hospitals and health centers. The company has also established relationships with major retailers to sell its products, such as CVS and Walgreens in the USA. In addition to its core products and services, Omnicell also provides training and support to customers to ensure they can make optimal use of their products. The company also has its own research and development department to continuously develop new and innovative products and solutions. Overall, Omnicell aims to transform the healthcare industry through innovative automation solutions. Through its products, services, and solutions, the company has already helped many healthcare facilities improve their processes and increase patient safety. Omnicell will continue to invest in the development of new products and technologies to optimize the healthcare industry in the long term. Omnicell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omnicell stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Omnicell is 11.67 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Omnicell changed from 337,000.00 USD to 11.67 M USD, representing a 3,361.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Omnicell since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Omnicell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Omnicell

All Key Metrics — Omnicell